- 8/2/2019 FDA Deems Certain Tobacco Products Subject to FDA Authority, Sales and Distribution Restrictions, and Health Warning Requirements for Packages and Advertisements: Guidance for Industry
- 8/2/2019 Testing and Labeling Medical Devices for Safety in the Magnetic Resonance (MR) Environment: Draft Guidance for Industry and Food and Drug Administration Staff
- 8/1/2019 Oncology Therapeutic Radiopharmaceuticals: Nonclinical Studies and Labeling Recommendations Guidance for Industry
- 7/31/2019 Bacterial Vaginosis: Developing Drugs for Treatment Guidance for Industry
- 7/31/2019 E8(R1) GENERAL CONSIDERATIONS FOR CLINICAL STUDIES
- 7/31/2019 General Clinical Pharmacology Considerations for Neonatal Studies for Drugs and Biological Products Guidance for Industry
- 7/31/2019 Pathology Peer Review in Nonclinical Toxicology Studies: Questions and Answers
- 7/31/2019 Uncomplicated Urinary Tract Infections: Developing Drugs for Treatment Guidance for Industry
- 7/31/2019 Vulvovaginal Candidiasis: Developing Drugs for Treatment
- 7/30/2019 Rare Pediatric Disease Priority Review Vouchers: Draft Guidance for Industry
.png)
No hay comentarios:
Publicar un comentario